• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基因沉默的壳聚糖-小干扰RNA复合纳米颗粒

[Chitosan-siRNA complex nanoparticles for gene silencing].

作者信息

Liu Xiudong

机构信息

College of Environment and Chemical Engineering, Dalian University, Dalian 116622, China.

出版信息

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):97-101.

PMID:20337033
Abstract

Small interference RNA (siRNA) induced RNA interference (RNAi) technology has shown high specificity and high efficiency of silencing target gene expression, and it is becoming a promising candidate drug for the therapy of cancer and viral infection diseases. At present, the lack of safe and effective carrier materials and delivery systems of siRNA through extracellular and intracellular barriers still hampers the clinical application. In order to overcome this difficulty, we proposed using chitosan, naturally occurring polycation, to form complex siRNA against green fluorescence protein (siRNA-eGFP). The spherical and stable chitosan-siRNA nanoparticles with 83%-94% siRNA complex efficiency can be formulated under mild electrostatic interaction. The size and Zeta potential of nanoparticles were within the range of 90-180 nm and 10-30 mV, respectively. 80% cell viability could be maintained inthe course of incubating with chitosan-siRNA nanoparticles. Moreover, nearly 80% gene silencing efficiency of chitosan-siRNA nanoparticles was realized.

摘要

小干扰RNA(siRNA)诱导的RNA干扰(RNAi)技术已显示出在沉默靶基因表达方面的高特异性和高效率,并且正成为治疗癌症和病毒感染性疾病的一种有前景的候选药物。目前,缺乏安全有效的载体材料以及siRNA穿过细胞外和细胞内屏障的递送系统仍然阻碍了其临床应用。为了克服这一困难,我们提出使用天然存在的聚阳离子壳聚糖来形成针对绿色荧光蛋白的复合siRNA(siRNA-eGFP)。在温和的静电相互作用下,可以制备出siRNA复合效率为83%-94%的球形且稳定的壳聚糖-siRNA纳米颗粒。纳米颗粒的尺寸和Zeta电位分别在90-180 nm和10-30 mV范围内。在用壳聚糖-siRNA纳米颗粒孵育过程中可维持80%的细胞活力。此外,壳聚糖-siRNA纳米颗粒实现了近80%的基因沉默效率。

相似文献

1
[Chitosan-siRNA complex nanoparticles for gene silencing].用于基因沉默的壳聚糖-小干扰RNA复合纳米颗粒
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):97-101.
2
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.聚合物性质对壳聚糖/小干扰RNA纳米颗粒制剂及基因沉默的影响。
Biomaterials. 2007 Feb;28(6):1280-8. doi: 10.1016/j.biomaterials.2006.11.004.
3
An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.一种可吸入的β₂-肾上腺素能受体配体导向的胍基化壳聚糖载体,用于将 siRNA 靶向递送至肺部。
J Control Release. 2012 Aug 20;162(1):28-36. doi: 10.1016/j.jconrel.2012.06.005. Epub 2012 Jun 12.
4
Chitosan as a carrier for targeted delivery of small interfering RNA.壳聚糖作为小干扰 RNA 靶向递送的载体。
Int J Pharm. 2010 Oct 31;399(1-2):1-11. doi: 10.1016/j.ijpharm.2010.08.022. Epub 2010 Aug 21.
5
Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.可磷酸化短肽偶联的低分子量壳聚糖用于高效 siRNA 递送和靶基因沉默。
Int J Pharm. 2012 Jan 17;422(1-2):445-53. doi: 10.1016/j.ijpharm.2011.10.041. Epub 2011 Oct 28.
6
Functional gene silencing mediated by chitosan/siRNA nanocomplexes.壳聚糖/小干扰RNA纳米复合物介导的功能性基因沉默
Nanotechnology. 2009 Oct 7;20(40):405103. doi: 10.1088/0957-4484/20/40/405103. Epub 2009 Sep 14.
7
Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.评价可生物降解共聚物的阳离子纳米颗粒作为治疗乙型肝炎的 siRNA 递送系统。
Int J Pharm. 2010 Nov 15;400(1-2):194-200. doi: 10.1016/j.ijpharm.2010.08.026. Epub 2010 Aug 27.
8
Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于质粒 DNA 递送和 HBV 基因沉默。
Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.
9
siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.壳聚糖纳米粒介导的 siRNA 递送:有利于高效基因沉默的分子特性。
J Control Release. 2012 Mar 10;158(2):261-8. doi: 10.1016/j.jconrel.2011.11.012. Epub 2011 Nov 17.
10
Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.选择合适的检测时间以准确评估小干扰RNA(siRNA)诱导的基因沉默效率。
J Biotechnol. 2005 Nov 21;120(3):251-61. doi: 10.1016/j.jbiotec.2005.06.014. Epub 2005 Aug 10.

引用本文的文献

1
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.壳聚糖、壳聚糖衍生物及壳聚糖金属纳米颗粒在药物递送中的制备、表征及潜在应用
Drug Des Devel Ther. 2016 Jan 28;10:483-507. doi: 10.2147/DDDT.S99651. eCollection 2016.
2
Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components.金纳米颗粒的壳聚糖功能化促进颗粒摄取,并在吞噬细胞中诱导细胞毒性和促炎状态,同时增强颗粒与血清成分的相互作用。
J Nanobiotechnology. 2015 Nov 18;13:84. doi: 10.1186/s12951-015-0146-9.
3
Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy.
评估树枝状生物可还原聚合物作为用于癌症治疗的小干扰RNA递送载体的性能。
J Control Release. 2015 Jul 10;209:179-85. doi: 10.1016/j.jconrel.2015.04.039. Epub 2015 Apr 30.
4
Recent advances of chitosan nanoparticles as drug carriers.壳聚糖纳米粒作为药物载体的最新进展。
Int J Nanomedicine. 2011;6:765-74. doi: 10.2147/IJN.S17296. Epub 2011 Apr 11.